Literature DB >> 19560801

Young patients with endometrial cancer: how many could be eligible for fertility-sparing treatment?

Isabelle Navarria1, Massimo Usel, Elisabetta Rapiti, Isabelle Neyroud-Caspar, Marie-Françoise Pelte, Christine Bouchardy, Patrick Petignat.   

Abstract

OBJECTIVES: To assess the characteristics of young women with endometrial carcinoma, and evaluate those potentially eligible for conservative therapy.
METHODS: We identified women diagnosed with endometrial cancer between 1970 and 2005 at the population-based Geneva Cancer Registry (n=1365). We classified patients into two age groups (< or =45 and >45 years old). Differences in demographic, tumor, diagnostic and treatment characteristics were tested with chi square. Kaplan-Meier analysis was used to calculate survival from endometrial cancer and the log-rank test to analyze differences in survival between the two groups.
RESULTS: The young group comprised 44 (3.2%) women and the old group 1321 (96.8%) women. Synchronous ovarian malignancies were found in six patients (14%) in the young group, compared with 23 (2%) in the old group (P<0.001). Tumor stage was also different between the two groups, principally because of more stage II among the young (P=0.012). Histological tumor type, grade and specific endometrial cancer 5-year survival did not significantly differ between the two groups. According to final histopathologic evaluation, eight patients from the young group had FIGO stage IA, grade I disease, i.e. may have been eligible for fertility-sparing treatment, corresponding to an incidence rate of 0.3/100,000.
CONCLUSION: No significant difference regarding tumor characteristics and survival between young and older patients was observed, except stage of disease and rate of synchronous ovarian malignancy. Conservative approach is a meaningful quality of life goal for patients with cancer, but only suitable for a limited number of patients.

Entities:  

Mesh:

Year:  2009        PMID: 19560801     DOI: 10.1016/j.ygyno.2009.05.038

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  20 in total

1.  Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control study.

Authors:  M M AlHilli; S C Dowdy; A L Weaver; J L St Sauver; G L Keeney; A Mariani; K C Podratz; J N Bakkum-Gamez
Journal:  Gynecol Oncol       Date:  2011-12-28       Impact factor: 5.482

2.  Sex-Based Disparities in the Hourly Earnings of Surgeons in the Fee-for-Service System in Ontario, Canada.

Authors:  Fahima Dossa; Andrea N Simpson; Rinku Sutradhar; David R Urbach; George Tomlinson; Allan S Detsky; Nancy N Baxter
Journal:  JAMA Surg       Date:  2019-12-01       Impact factor: 14.766

Review 3.  Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer.

Authors:  Jeong-Yeol Park; Joo-Hyun Nam
Journal:  Oncologist       Date:  2015-02-11

4.  An MRI radiomics nomogram improves the accuracy in identifying eligible candidates for fertility-preserving treatment in endometrioid adenocarcinoma.

Authors:  Bi-Cong Yan; Feng-Hua Ma; Ying Li; Yan-Feng Fan; Zhi-Long Huang; Xiao-Liang Ma; Xue-Ting Wen; Jin-Wei Qiang
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

5.  Controversies in the management of endometrial carcinoma.

Authors:  Ying Zhang; Jian Wang
Journal:  Obstet Gynecol Int       Date:  2010-06-22

6.  Multiparametric magnetic resonance imaging facilitates the selection of patients prior to fertility-sparing management of endometrial cancer.

Authors:  Yuki Himoto; Yulia Lakhman; Shinya Fujii; Satoshi Morita; Jennifer J Mueller; Mario M Leitao; Aki Kido
Journal:  Abdom Radiol (NY)       Date:  2021-04-07

7.  Fertility-Sparing Treatment for Atypical Endometrial Hyperplasia and Endometrial Cancer: A Cochrane Systematic Review Protocol.

Authors:  Maria-Eulalia Fernandez-Montoli; Jordi Sabadell; Nayanar-Adela Contreras-Perez
Journal:  Adv Ther       Date:  2021-04-08       Impact factor: 3.845

8.  Characteristics and prognosis of coexisting adnexa malignancy with endometrial cancer: a single institution review of 51 cases.

Authors:  Lu Chen; Qiang Zhao; Xiaojuan Lv
Journal:  Arch Gynecol Obstet       Date:  2010-06-29       Impact factor: 2.344

9.  Endometrial adenocarcinoma in a 27-year-old woman.

Authors:  Anis Fadhlaoui; Jamel Ben Hassouna; Mohamed Khrouf; Fethi Zhioua; Anis Chaker
Journal:  Clin Med Insights Case Rep       Date:  2010-08-12

Review 10.  Endometrial cancer from early to advanced-stage disease: an update for radiologists.

Authors:  Cibele Luna; Patricia Balcacer; Patricia Castillo; Marilyn Huang; Francesco Alessandrino
Journal:  Abdom Radiol (NY)       Date:  2021-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.